Skip to content
Open access

The CRUMB study: closed-loop response to unannounced mixed and carbohydrates-rich breakfasts. A randomized controlled crossover pilot-study in a cohort of adolescents with type 1 diabetes

Jul 2026 · Endocrine · Vol 91 · 0 citations · 27 references
Medicine

TL;DR

The PID demonstrated higher reactivity to unannounced meals, while performances were comparable when meal boluses were properly announced, and both AID algorithms mitigated postprandial glycemia and returned glucose to baseline levels within 4 h without safety concerns.

Abstract

Unannounced meals pose a major challenge to type 1 diabetes patients. This study compared the performance of two automated insulin delivery (AID) algorithms, the Medtronic MiniMed 780G’s proportional-integral-derivative (PID) and the Tandem t: slim X2’s model predictive control (MPC), following unannounced breakfasts (ClinicalTrials.gov identifier: NCT07455643, retrospectively registered the 3rd of February 2026). In a randomized crossover study, we enrolled 20 children between 11 and 18 years using the MiniMed 780G or the Tandem t: slim X2 AID system. Endpoints included 2-hour and 4-hour blood glucose difference (ΔBG), glucose peak, time to peak, and time spent above (TAR), below (TBS), in range (TIR), and in tight range (TITR). Two meals were tested: a carbohydrate (CHO) meal and a mixed one, both containing 30 g of carbohydrates, and additional 15 g proteins for the mixed meal. Announced (AM) and unannounced (UM) meals were analyzed. AM, compared to UM, showed significant higher 2-hourΔBG; conversely 4-hourΔBG did not differ significantly. In CHO AM, algorithms were comparable. In mixed AM, PID gained lower peaks and TAR, with higher TIR and TITR. In UM, PID obtained lower 2-hourΔBG than MPC, with reduced peak, TAR, and improved TIR and TITR. Differences in 4-hourΔBG and time-at-peak were not significant. Both AID algorithms mitigated postprandial glycemia and returned glucose to baseline levels within 4 h without safety concerns. The PID demonstrated higher reactivity to unannounced meals, while performances were comparable when meal boluses were properly announced. NCT07455643.

Read PDF

Similar papers

Aug 2026

Two-Year Real-Life Achievements of MiniMed 780G Advanced Closed-Loop System in Youth with Type 1 Diabetes: AWeSoMe Study Group Multicenter Prospective Extended Follow-Up.

OBJECTIVE To determine whether glycemic benefits of the MiniMed 780G Advanced Hybrid Closed-Loop (AHCL) system are sustained over two years in youth with type 1 diabetes (T1D), and to identify outcome predictors. METHODS This prospective multicenter study collected CGM and clinical data at 1,3,6,12, and 24 months in...

Y Lebenthal, Talia Jacobi-Polishook, Shirli Abiri et al. · 0 citations
Open access Sep 2026

Bihormonal fully closed-loop glucose control in adolescents with Type 1 diabetes: an outpatient, randomized, crossover trial

Effective diabetes management in adolescents with Type 1 diabetes is crucial to reduce the risk of long-term complications. However, adolescents show the poorest glycemic outcomes of all age groups. A bihormonal fully closed-loop (FCL) system, which requires no user input, may help address these challenges. In this tri...

Richell S. Booijink, Job S. de Haan, Loes van den Berg et al. · 0 citations
Open access Sep 2026

Impact of the use of Extended™ Wear Infusion sets on metabolic, ultrasound, and psychological outcomes in adults with type 1 diabetes using the Medtronic MiniMed 780G: a pilot randomized controlled trial.

INTRODUCTION In people with type 1 diabetes (PwT1DM), insulin infusion sets (IIS) are often regarded as the most fragile componentof insulin pump therapy. Standard IISs should be replaced every 2-3 days to prevent site complications and hyperglycemia. The objectiveof this randomized controlled trial was to evaluate the...

Kamila Susuł, Damian Ucieklak, K. Cyranka et al. · 0 citations
Conference Open access 2026

Evaluation of Study Designs and Therapeutic Effects of Different Treatments in Type 1 Diabetes: A narrative review

This in-depth analysis explores the clinical performance and safety profiles of multiple cutting-edge diabetes management tools and treatment approaches in type 1 diabetes patients. The initial research assesses the advanced hybrid closed-loop (AHCL) system (Medtronic MiniMed 780G) among pediatric and adolescent popula...

Shu-Ru Chen · 0 citations
Open access Sep 2026

Postprandial ultra-fast insulin versus mealtime fast-acting insulin in adults with cystic fibrosis-related diabetes: A randomized multicentre crossover trial.

AIMS Postprandial administration of ultra-fast-acting insulin (PP-UFI) may offer greater flexibility for individuals with cystic fibrosis-related diabetes (CFRD). This study evaluated whether PP-UFI provides glycaemic control comparable to standard mealtime fast-acting insulin (MT-FI). METHODS Adults with CFRD were e...

Luc Rakotoarisoa, P. Mulette, R. Chiron et al. · 0 citations
Open access Sep 2026

EFFECTS OF SOLEUS PUSH-UP EXERCISE ON GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A RANDOMIZED CONTROLLED TRIAL

Objective: This study aimed to evaluate whether a 12-week seated soleus push-up exercise program, added to standard diabetes care, improves fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c) in patients with type 2 diabetes mellitus (T2DM). Methods: This open-label, two-arm randomized controlled trial was con...

Sreekumar Ragupathy, T. Kanagaraj, K. Sadasivam et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.